Table 3.
Descriptive analysis of secondary endpoints with standardized mean differences (SMDs)
| Sensitive (control) | Resistant (case) | SMD | |
|---|---|---|---|
| n | 75 | 75 | |
| Death hospital, died in hospital < 30 d after resistance test (%) | 12 (16.0) | 7 (9.3) | 0.201 |
| Death (%) | 0.232 | ||
| Alive 30 d after resistance testing | 53 (70.7) | 54 (72.0) | |
| Died < 30 d after resistance testing | 12 (16.0) | 7 (9.3) | |
| NA2 | 10 (13.3) | 14 (18.7) | |
| ICU total (days) (mean (SD)) | 4.5 (7.9) | 8.6 (16.4) | 0.315 |
| Hospitalization total (days) (mean (SD)) | 25.8 (21.2) | 34.1 (41.3) | 0.253 |
| Re-hospitalization 1 (%) | 12 (16.0) | 9 (12.0) | 0.115 |
| Antibiotics total (days) (mean (SD)) | 34.9 (42.0) | 45.3 (61.2) | 0.197 |
1Rehospitalization at the USB within 30 days after the end of stationary care
2End of hospitalization within 30 days after resistance testing. No information could be gathered about mortality